Chip sector suffers unanimous selloff, led by stocks of AMD, Intel and ASML
The semiconductor sector suffered a unanimous selloff to start 2024, the day after posting the best yearly gain in 20 years. The VanEck Semiconductor ETF (SMH) slumped 3.4% in Tuesday trading, with all 25 equity components trading lower. The ETF had run up 72.3% in 2023, the best year for the ETF since it soared a record 87.3% in 2003. Tuesday's biggest decliner was Advanced Micro Devices Inc. (AMD) shares, which shed about 6%. Intel's stock (INTC) took a 4.9% hit, after rocketing 90.1% in 2023, the stock's best year since it shot up 105.8% in 2003. Meanwhile, the U.S.-listed shares of ASML Holding N.V. (ASML) slid 5.3% to be the third-worst performer in the ETF, after the Netherlands-based chip-equipment maker was reportedly blocked from exporting some equipment to China, amid security concerns expressed by the Netherlands, Japan and the U.S. The best performer in the chip ETF, as well as the S&P 500 , in 2023 was Nvidia Corp.'s stock (NVDA), which rocketed 238.9% to post the best year since the record 308.4% rally in 2001. The stock lost 2.8% on Tuesday.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-02-24 1705ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise